Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis”
Crossref DOI link: https://doi.org/10.1007/s12325-023-02491-4
Published Online: 2023-04-01
Published Print: 2023-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Marshall, Jonathan
Sharma, Akanksha
Darken, Patrick
Ouwens, Mario
Singh, Barinder
Tansey-Dwyer, Deniz
Funding for this research was provided by:
AstraZeneca
Text and Data Mining valid from 2023-04-01
Version of Record valid from 2023-04-01
Article History
Received: 15 November 2022
Accepted: 9 March 2023
First Online: 1 April 2023